Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 181

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Dichloroacetate (DCA) sensitizes both wild‐type and over expressing Bcl‐2 prostate cancer cells in vitro to radiation

Cao, Wengang, Yacoub, Saif, Shiverick, Kathleen T., Namiki, Kazunori, Sakai, Yoshihisa, Porvasnik, Stacy, Urbanek, Cydney, Rosser, Charles J.·2008·The Prostate

Abstract

Background: Bcl‐2 protects cells from apoptosis and provides a survival advantage to cells over‐expressing this oncogene. In addition, over expression of Bcl‐2 renders cell resistant to radiation therapy. Recently, dichloroacetate (DCA) was proven to potentiate the apoptotic machinery by interacting with Bcl‐2. In this study, we investigated whether treating human prostate cancer cells with DCA could modulate Bcl‐2 expression and if the modulation in Bcl‐2 expression could render the Bcl‐2 over expressing cells more susceptible to cytotoxicity effects of radiation. Methods: PC‐3‐Bcl‐2 and PC‐3‐Neo human prostate cancer cells treated with DCA in addition to irradiation were analyzed in vitro for changes in proliferation, clonogenic survival, apoptosis, cell cycle phase distribution, mitochondrial membrane potential, and expression of Bcl‐2, Bcl‐xL, Bax, or Bak proteins. Results: DCA alone produced significant cytotoxic effects and was associated with G1 cell cycle arrest. Furthermore, DCA was associated with an increased rate of apoptosis. The combination of DCA with irradiation sensitized both cell lines to radiation's killing effects. Treatment of PC‐3‐Bcl‐2 or PC‐3‐Neo with DCA and irradiation resulted in marked changes in various members of the Bcl‐2 family. In addition, DCA therapy resulted in a significant change in mitochondria membrane potential, thus supporting the notion that DCAs effect is on the mitochondria. Conclusions: This is the first study to demonstrate DCA can effectively sensitize wild‐type and over expressing Bcl‐2 human prostate cancer cells to radiation by modulating the expression of key members of the Bcl‐2 family. Together, these findings warrant further evaluation of the combination of DCA and irradiation. Prostate 68: 1223–1231, 2008. © 2008 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/pros.20788

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 181

Metadata

Authors
Cao, W., Yacoub, S., Shiverick, K. T., Namiki, K., Sakai, Y., Porvasnik, S., Urbanek, C., & Rosser, C. J.
Venue
The Prostate
Publisher
Wiley
Published
2008-05-08
Volume
68
Issue
11
Pages
1223-1231
ISSN
  • 0270-4137 (ISSN-L)
  • 1097-0045
OpenAlex
W2097104496
Cited by
181
References
1
FWCI
3.97
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dichloroacetate (DCA) sensitizes both wild‐type and over expressing Bcl‐2 prostate cancer cells in vitro to radiation. https://app.cochat.ai/papers/10.1002/pros.20788
The paper
Cao, W., Yacoub, S., Shiverick, K. T., Namiki, K., Sakai, Y., Porvasnik, S., Urbanek, C., & Rosser, C. J. (2008). Dichloroacetate (DCA) sensitizes both wild‐type and over expressing Bcl‐2 prostate cancer cells in vitro to radiation. The Prostate. https://doi.org/10.1002/pros.20788

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.